{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:03:09Z","timestamp":1789984989598,"version":"4.0.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Immigrant Minority Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Latino adults in South Los Angeles living with type 2 diabetes mellitus (T2DM) experience disproportionate cardiometabolic complications alongside structural barriers that influence medication regimen complexity (MRC) and medication access. During 2017\u20132022, diabetes treatment guidelines increasingly emphasized cardioprotective antihyperglycemic medications while concurrent federal and state policy changes influenced health coverage continuity and pharmacy access for underserved populations. The present study evaluated the association between diabetes specific MRC (DM MRC) and cardiometabolic outcomes (glycemic, atherogenic cholesterol and blood pressure control) among underserved Latino adults living with T2DM and examined the implications of these relationships for pharmacoequity within the context of medication access and health system design. A single-center, cross-sectional retrospective chart review was conducted among 342 adults receiving primary care at a federally qualified health center in South Los Angeles between January 2017 and October 2022. Logistic regression analyses revealed a significant association between higher DM MRC and lower likelihood of glycemic control. Participants with moderate and high DM MRC were less likely to achieve glycemic control compared to those with low DM MRC. No associations were observed between diabetes specific MRC and atherogenic cholesterol and blood pressure control. There was a low uptake of cardioprotective medications such as sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists among the study population. Insurance status was also negatively and independently associated with glycemic control, highlighting the role of structural determinants and coverage related barriers in diabetes management. These findings suggest that DM MRC operates within a policy and pharmacoequity context in which insurance transitions, formulary restrictions, and administrative barriers may negatively impact access to evidence-based antihyperglycemic medications in structurally vulnerable populations. Pharmacist-integrated care models and policies that improve continuity of medication access and uptake of optimal diabetes medications may help reduce inequities in diabetes outcomes.<\/jats:p>","DOI":"10.1007\/s10903-026-01999-5","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:31:53Z","timestamp":1789983113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes Medication Regimen Complexity and Glycemic Outcomes among Medically Underserved Latino Adults: Implications for Pharmacoequity"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-7384","authenticated-orcid":false,"given":"Cheryl","family":"Wisseh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaylen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7751-5112","authenticated-orcid":false,"given":"Margarita","family":"Loeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Opara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loan T.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"1999_CR1","unstructured":"United States Census Bureau. Decennial Census Profile of General Population and Housing Characteristics [Internet]. data.census.gov. 2026 [cited 2025 Mar 11]. https:\/\/data.census.gov\/table?t=Hispanic+or+Latino&g=010XX00US_040XX00US06&d=DEC+Demographic+Profile. Accessed 11 Mar 2025."},{"key":"1999_CR2","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report [Internet]. Centers for Disease Control and Prevention; 2026. https:\/\/gis.cdc.gov\/grasp\/diabetes\/diabetesatlas-statsreport.html. cited 2026 May 17; Accessed 17 May 2026."},{"key":"1999_CR3","unstructured":"Los Angeles County Department of Public Health. Community Health Profiles SPA 6: South [Internet]. County of Los Angeles Public Health; 2024. https:\/\/apps.gis.lacounty.gov\/static\/DPH\/community-profiles\/?Geo_ID=spa_6. cited 2026 Feb 26. Accessed 26 Feb 2026."},{"key":"1999_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148:1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"key":"1999_CR5","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.2337\/dc26-S012","volume":"49","author":"M Bajaj","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes\u20142026. Diabetes Care. 2026;49:S261\u201376. https:\/\/doi.org\/10.2337\/dc26-S012.","journal-title":"Diabetes Care"},{"key":"1999_CR6","doi-asserted-by":"publisher","first-page":"S246","DOI":"10.2337\/dc26-S011","volume":"49","author":"M Bajaj","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes\u20142026. Diabetes Care. 2026;49:S246\u201360. https:\/\/doi.org\/10.2337\/dc26-S011.","journal-title":"Diabetes Care"},{"key":"1999_CR7","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.2337\/dc26-S010","volume":"49","author":"M Bajaj","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes\u20142026. Diabetes Care. 2026;49:S216\u201345. https:\/\/doi.org\/10.2337\/dc26-S010.","journal-title":"Diabetes Care"},{"key":"1999_CR8","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.2337\/dc26-S009","volume":"49","author":"M Bajaj","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142026. Diabetes Care. 2026;49:S183\u2013215. https:\/\/doi.org\/10.2337\/dc26-S009.","journal-title":"Diabetes Care"},{"key":"1999_CR9","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2147\/COPD.S136256","volume":"12","author":"N Negewo","year":"2017","unstructured":"Negewo N, Gibson P, Wark P, Simpson J, McDonald V. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. COPD. 2017;12:2929\u201342. https:\/\/doi.org\/10.2147\/COPD.S136256.","journal-title":"COPD"},{"key":"1999_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ekir.2020.10.011","volume":"6","author":"J Marienne","year":"2021","unstructured":"Marienne J, Laville SM, Caillard P, Batteux B, Gras-Champel V, Masmoudi K, et al. Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation. Kidney Int Rep. 2021;6:128\u201337. https:\/\/doi.org\/10.1016\/j.ekir.2020.10.011.","journal-title":"Kidney Int Rep"},{"key":"1999_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2147\/CIA.S130832","volume":"12","author":"M Cobretti","year":"2017","unstructured":"Cobretti M, Page Ii R, Linnebur S, Deininger K, Ambardekar A, Lindenfeld J, et al. Medication regimen complexity in ambulatory older adults with heart failure. CIA. 2017;12:679\u201386. https:\/\/doi.org\/10.2147\/CIA.S130832.","journal-title":"CIA"},{"key":"1999_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/1060028015621071","volume":"50","author":"BC Wimmer","year":"2016","unstructured":"Wimmer BC, Bell JS, Fastbom J, Wiese MD, Johnell K. Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study. Ann Pharmacother. 2016;50:89\u201395. https:\/\/doi.org\/10.1177\/1060028015621071.","journal-title":"Ann Pharmacother"},{"key":"1999_CR13","doi-asserted-by":"publisher","first-page":"e002348","DOI":"10.1136\/bmjdrc-2021-002348","volume":"9","author":"M Luzuriaga","year":"2021","unstructured":"Luzuriaga M, Leite R, Ahmed H, Saab PG, Garg R. Complexity of antidiabetic medication regimen is associated with increased diabetes-related distress in persons with type 2 diabetes mellitus. BMJ Open Diab Res Care. 2021;9:e002348. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002348.","journal-title":"BMJ Open Diab Res Care"},{"key":"1999_CR14","doi-asserted-by":"publisher","first-page":"808190","DOI":"10.3389\/fphar.2022.808190","volume":"13","author":"N Ab Rahman","year":"2022","unstructured":"Ab Rahman N, Lim MT, Thevendran S, Ahmad Hamdi N, Sivasampu S. Medication Regimen Complexity and Medication Burden Among Patients With Type 2 Diabetes Mellitus: A Retrospective Analysis. Front Pharmacol. 2022;13:808190. https:\/\/doi.org\/10.3389\/fphar.2022.808190.","journal-title":"Front Pharmacol"},{"key":"1999_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/1060028016673652","volume":"51","author":"A Yeh","year":"2017","unstructured":"Yeh A, Shah-Manek B, Lor KB. Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 Diabetes: A Cross-sectional Study. Ann Pharmacother. 2017;51:111\u20137. https:\/\/doi.org\/10.1177\/1060028016673652.","journal-title":"Ann Pharmacother"},{"key":"1999_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.japh.2022.12.028","volume":"63","author":"AM Russell","year":"2023","unstructured":"Russell AM, Opsasnick L, Yoon E, Bailey SC, O\u2019Brien M, Wolf MS. Association between medication regimen complexity and glycemic control among patients with type 2 diabetes. J Am Pharmacists Association. 2023;63:769\u201377. https:\/\/doi.org\/10.1016\/j.japh.2022.12.028.","journal-title":"J Am Pharmacists Association"},{"key":"1999_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/pharmacy12030083","volume":"12","author":"C Wisseh","year":"2024","unstructured":"Wisseh C, Adinkrah E, Opara L, Melone S, Udott E, Bazargan M, et al. Associations between Diabetes-Specific Medication Regimen Complexity and Cardiometabolic Outcomes among Underserved Non-Hispanic Black Adults Living with Type 2 Diabetes Mellitus. Pharmacy. 2024;12:83. https:\/\/doi.org\/10.3390\/pharmacy12030083.","journal-title":"Pharmacy"},{"key":"1999_CR18","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1001\/jama.2021.17764","volume":"326","author":"UR Essien","year":"2021","unstructured":"Essien UR, Dusetzina SB, Gellad WF. A Policy Prescription for Reducing Health Disparities\u2014Achieving Pharmacoequity. JAMA. 2021;326:1793. https:\/\/doi.org\/10.1001\/jama.2021.17764.","journal-title":"JAMA"},{"key":"1999_CR19","doi-asserted-by":"publisher","DOI":"10.56021\/9781421437903","volume-title":"The Political Determinants of Health","author":"DE Dawes","year":"2020","unstructured":"Dawes DE. The Political Determinants of Health. Baltimore, MD: Johns Hopkins University; 2020."},{"key":"1999_CR20","doi-asserted-by":"publisher","first-page":"e2612332","DOI":"10.1001\/jamanetworkopen.2026.12332","volume":"9","author":"R Leonard","year":"2026","unstructured":"Leonard R, Lipton BJ. The California 2020 Medi-Cal Expansion to Young Adults and Coverage Among Noncitizens. JAMA Netw Open. 2026;9:e2612332. https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.12332.","journal-title":"JAMA Netw Open"},{"key":"1999_CR21","unstructured":"Bustamante AV, Beltran LF, Cuadros N, Zeng XL, Gonzalez S. Implementation Lessons From the 2022 Medi-Cal Expansion to Undocumented Adults Aged Fifty and Above [Internet]. University of California Los Angeles Latino Policy & Politics Institute; 2023 July. https:\/\/latino.ucla.edu\/research\/lessons-2022-adult-medical-expansion\/. Accessed 28 Apr 2026."},{"key":"1999_CR22","unstructured":"Dietz M, Kadiyala S, Lucia L, Challenor T, Rak A, Chen Y et al. California\u2019s Uninsured in 2024: Medi-Cal Expands to All Low-Income Adults, But Half a Million Undocumented Californians Lack Affordable Coverage Options [Internet]. University of California Los Angeles Center for Health Policy Research and University of California Berkeley Labor Center; 2023 Mar. https:\/\/healthpolicy.ucla.edu\/our-work\/publications\/californias-uninsured-2024-medi-cal-expands-all-low-income-adults-half-million-undocumented. Accessed 28 Apr 2026."},{"key":"1999_CR23","unstructured":"Department of Health Care Services. Medi-Cal Rx: Transitioning Medi-Cal Pharmacy Services from Managed Care to Fee-For-Service Frequently Asked Questions [Internet]. Medi-Cal Rx Frequently Asked Questions. 2023 [cited 2026 Apr 28]. https:\/\/www.dhcs.ca.gov\/provgovpart\/pharmacy\/Pages\/Medi-Cal-Rx-FAQ.aspx. Accessed 28 Apr 2026."},{"key":"1999_CR24","unstructured":"Health Services Los Angeles County. My Health LA Sunsets [Internet]. Department of Health Care Services Los Angeles County. 2024 [cited 2026 Apr 28]. https:\/\/dhs.lacounty.gov\/my-health-la-sunsets\/. Accessed 28 Apr 2026."},{"key":"1999_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/phar.1452","volume":"34","author":"JD Hirsch","year":"2014","unstructured":"Hirsch JD, Metz KR, Hosokawa PW, Libby AM. Validation of a Patient-Level Medication Regimen Complexity Index as a Possible Tool to Identify Patients for Medication Therapy Management Intervention. Pharmacotherapy. 2014;34:826\u201335. https:\/\/doi.org\/10.1002\/phar.1452.","journal-title":"Pharmacotherapy"},{"key":"1999_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clinthera.2013.02.019","volume":"35","author":"AM Libby","year":"2013","unstructured":"Libby AM, Fish DN, Hosokawa PW, Linnebur SA, Metz KR, Nair KV, et al. Patient-Level Medication Regimen Complexity Across Populations With Chronic Disease. Clin Ther. 2013;35:385\u2013e3981. https:\/\/doi.org\/10.1016\/j.clinthera.2013.02.019.","journal-title":"Clin Ther"},{"key":"1999_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.18553\/jmcp.2016.22.5.516","volume":"22","author":"AJ Adams","year":"2016","unstructured":"Adams AJ, Stolpe SF. Defining and Measuring Primary Medication Nonadherence: Development of a Quality Measure. JMCP. 2016;22:516\u201323. https:\/\/doi.org\/10.18553\/jmcp.2016.22.5.516.","journal-title":"JMCP"},{"key":"1999_CR28","doi-asserted-by":"publisher","first-page":"E1000","DOI":"10.1503\/cmaj.221018","volume":"195","author":"S Zeitouny","year":"2023","unstructured":"Zeitouny S, Cheng L, Wong ST, Tadrous M, McGrail K, Law MR. Prevalence and predictors of primary nonadherence to medications prescribed in primary care. CMAJ. 2023;195:E1000\u20139. https:\/\/doi.org\/10.1503\/cmaj.221018.","journal-title":"CMAJ"},{"key":"1999_CR29","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373:2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"N Engl J Med"},{"key":"1999_CR30","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383:1413\u201324. https:\/\/doi.org\/10.1056\/NEJMoa2022190.","journal-title":"N Engl J Med"},{"key":"1999_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375:311\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1603827.","journal-title":"N Engl J Med"},{"key":"1999_CR32","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375:1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med"},{"key":"1999_CR33","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380:2295\u2013306. https:\/\/doi.org\/10.1056\/NEJMoa1811744.","journal-title":"N Engl J Med"},{"key":"1999_CR34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.106266","author":"MF Obi","year":"2026","unstructured":"Obi MF, Ahmad S, Ezechukwu K. Unequal Access to Evidence-Based Cardiometabolic Therapies: Racial Disparities in SGLT2 Inhibitor and GLP-1 Receptor Agonist Use Among Patients With Type 2 Diabetes and Cardiovascular Disease. Cureus [Internet]. 2026. https:\/\/doi.org\/10.7759\/cureus.106266. [cited 2026 May 18].","journal-title":"Cureus [Internet]"},{"key":"1999_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2337\/ds19-0019","volume":"33","author":"AS Bzowyckyj","year":"2020","unstructured":"Bzowyckyj AS, Begert JE, Diabetes. Therapeutic Inertia, and Patients\u2019 Medication Experience. Diabetes Spectr. 2020;33:31\u20137. https:\/\/doi.org\/10.2337\/ds19-0019.","journal-title":"Diabetes Spectr"},{"key":"1999_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/pmed.2000.0699","volume":"31","author":"RG Boyle","year":"2000","unstructured":"Boyle RG, O\u2019Connor P, Pronk N, Tan A. Health Behaviors of Smokers, Ex-Smokers, and Never Smokers in an HMO. Prev Med. 2000;31:177\u201382. https:\/\/doi.org\/10.1006\/pmed.2000.0699.","journal-title":"Prev Med"},{"key":"1999_CR37","doi-asserted-by":"publisher","first-page":"e2232778","DOI":"10.1001\/jamanetworkopen.2022.32778","volume":"5","author":"M Inoue-Choi","year":"2022","unstructured":"Inoue-Choi M, Ramirez Y, Fukunaga A, Matthews CE, Freedman ND. Association of Adherence to Healthy Lifestyle Recommendations With All-Cause and Cause-Specific Mortality Among Former Smokers. JAMA Netw Open. 2022;5:e2232778. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.32778.","journal-title":"JAMA Netw Open"},{"key":"1999_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/abm\/kaae021","volume":"58","author":"CC Silva","year":"2024","unstructured":"Silva CC, Presseau J, Van Allen Z, Schenk PM, Moreto M, Dinsmore J, et al. Effectiveness of Interventions for Changing More Than One Behavior at a Time to Manage Chronic Conditions: A Systematic Review and Meta-analysis. Ann Behav Med. 2024;58:432\u201344. https:\/\/doi.org\/10.1093\/abm\/kaae021.","journal-title":"Ann Behav Med"},{"key":"1999_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/jamainternmed.2014.6674","volume":"175","author":"JS Haas","year":"2015","unstructured":"Haas JS, Linder JA, Park ER, Gonzalez I, Rigotti NA, Klinger EV, et al. Proactive Tobacco Cessation Outreach to Smokers of Low Socioeconomic Status: A Randomized Clinical Trial. JAMA Intern Med. 2015;175:218. https:\/\/doi.org\/10.1001\/jamainternmed.2014.6674.","journal-title":"JAMA Intern Med"},{"key":"1999_CR40","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1186\/s12889-021-11982-4","volume":"21","author":"E Zabaleta-del-Olmo","year":"2021","unstructured":"Zabaleta-del-Olmo E, Casajuana-Closas M, L\u00f3pez-Jim\u00e9nez T, Pombo H, Pons-Vigu\u00e9s M, Pujol-Ribera E, et al. Multiple health behaviour change primary care intervention for smoking cessation, physical activity and healthy diet in adults 45 to 75 years old (EIRA study): a hybrid effectiveness-implementation cluster randomised trial. BMC Public Health. 2021;21:2208. https:\/\/doi.org\/10.1186\/s12889-021-11982-4.","journal-title":"BMC Public Health"},{"key":"1999_CR41","doi-asserted-by":"publisher","unstructured":"Pleym K, Dammen T, Wedon-Fekj\u00e6r H, Husebye E, Sverre E, Tonstad S et al. A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial. Szummer K, editor. European Heart Journal Open. 2024;4:oeae028. https:\/\/doi.org\/10.1093\/ehjopen\/oeae028","DOI":"10.1093\/ehjopen\/oeae028"},{"key":"1999_CR42","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2105\/AJPH.2018.304388","volume":"108","author":"S Glied","year":"2018","unstructured":"Glied S. Implications of the 2017 Tax Cuts and Jobs Act for Public Health. Am J Public Health. 2018;108:734\u20136. https:\/\/doi.org\/10.2105\/AJPH.2018.304388.","journal-title":"Am J Public Health"},{"key":"1999_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1377\/hlthaff.2018.05161","volume":"38","author":"V Fung","year":"2019","unstructured":"Fung V, Liang CY, Shi J, Seo V, Overhage L, Dow WH, et al. Potential Effects Of Eliminating The Individual Mandate Penalty In California. Health Aff. 2019;38:147\u201354. https:\/\/doi.org\/10.1377\/hlthaff.2018.05161.","journal-title":"Health Aff"},{"key":"1999_CR44","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10754-022-09324-x","volume":"22","author":"A Soni","year":"2022","unstructured":"Soni A. The impact of the repeal of the federal individual insurance mandate on uninsurance. Int J Health Econ Manag. 2022;22:423\u201341. https:\/\/doi.org\/10.1007\/s10754-022-09324-x.","journal-title":"Int J Health Econ Manag"},{"key":"1999_CR45","unstructured":"Bernstein H, Gonzalez D, Karpman M, Zuckerman S. May. Amid Confusion over the Public Charge Rule, Immigrant Families Continued Avoiding Public Benefits in 2019 [Internet]. Urban Institute; https:\/\/www.urban.org\/research\/publication\/amid-confusion-over-public-charge-rule-immigrant-families-continued-avoiding-public-benefits-2019. Accessed 11 2026."},{"key":"1999_CR46","unstructured":"Tolbert J, Pham O, Artiga S, Impact of Shifitng Immigration Policy on Medicaid Enrollment and Utilization of Care among Health Center Patients [Internet]. Henry J Kaiser Family Foundation; 2019 Oct. https:\/\/www.kff.org\/medicaid\/impact-of-shifting-immigration-policy-on-medicaid-enrollment-and-utilization-of-care-among-health-center-patients\/#e963324f-228c-4232-a409-8b8367e64bf6. Accessed 28 Apr 2026."},{"key":"1999_CR47","unstructured":"Congress.gov. H.R.6201-Families First Coronanvirus Response Act [Internet]. CONGRESS.GOV. 2020 [cited 2026 Apr 28]. https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/6201. Accessed 28 Apr 2026."},{"key":"1999_CR48","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1111\/1475-6773.70034","volume":"61","author":"W Lyu","year":"2026","unstructured":"Lyu W, Wehby GL. Effects of Continuous Medicaid Coverage in 2020\u20132023 on Children\u2019s Health Insurance Coverage, Access to Care, Health Services Use by Type, and Health Status. Health Serv Res. 2026;61:e70034. https:\/\/doi.org\/10.1111\/1475-6773.70034.","journal-title":"Health Serv Res"},{"key":"1999_CR49","unstructured":"Gonzalez D, Karpman M, Caraveo CA. Immigrant Families in California Faced Barriers Accessing Safety Net Programs in 2021, but Community Organizations Helped Many Enroll [Internet]. Urban Institute;, Aug. https:\/\/www.urban.org\/research\/publication\/immigrant-families-california-faced-barriers-accessing-safety-net-programs. Accessed 11 May 2026."},{"key":"1999_CR50","unstructured":"Roldan C. You Wouldn\u2019t Believe Me If I Said it Was Because of the Language Barrier: Administrative and Cultural Obstacles to Medicaid Enrollment [Internet]. Immigration Research Initiative;, Mar. https:\/\/immresearch.org\/publications\/you-wouldnt-believe-me-if-i-said-it-was-because-of-the-language-barrier-administrative-and-cultural-barriers-to-medicaid-enrollment-for-immigrants\/. Accessed 28 Apr 2026."},{"key":"1999_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.32481\/djph.2022.10.006","volume":"8","author":"FJ Alarcon","year":"2022","unstructured":"Alarcon FJ. The Migrant Crisis and Access to Health Care. Del J Public Health. 2022;8:20\u20135. https:\/\/doi.org\/10.32481\/djph.2022.10.006.","journal-title":"Del J Public Health"},{"key":"1999_CR52","unstructured":"Kaiser Family Foundation. Key Facts on Health Coverage of Immigrants [Internet]. KFF. 2025 [cited 2026 May 11]. https:\/\/www.kff.org\/racial-equity-and-health-policy\/key-facts-on-health-coverage-of-immigrants\/. Accessed 11 May 2026."},{"key":"1999_CR53","doi-asserted-by":"publisher","first-page":"e253887","DOI":"10.1001\/jamahealthforum.2025.3887","volume":"6","author":"A McIntyre","year":"2025","unstructured":"McIntyre A, Morein M, Kim J, Figueroa JF, Sommers BD. US Coverage Changes During Medicaid Unwinding in 2023. JAMA Health Forum. 2025;6:e253887. https:\/\/doi.org\/10.1001\/jamahealthforum.2025.3887.","journal-title":"JAMA Health Forum"},{"key":"1999_CR54","unstructured":"Roldan C, Settle S. My Papers Were Incomplete and It Kept Being Denied: Challenges with the Medicaid Renewal Process [Internet]. Immigration Research Initiative; 2024 Feb. https:\/\/immresearch.org\/publications\/my-papers-were-incomplete-and-it-kept-being-denied-challenges-with-the-medicaid-renewal-process\/. Accessed 28 Apr 2026."},{"key":"1999_CR55","unstructured":"Musumeci MB, Murphy C, Leiser E, Silverman H, Azimpoor K. Reducing Medicaid Churn: Policies to Promote Stabel Health Coverage and Access to Care [Internet]. The Commonwealth Fund;, June. https:\/\/www.commonwealthfund.org\/publications\/issue-briefs\/2025\/jun\/reducing-medicaid-churn-policies-promote-stable-health-coverage. Accessed 11 May 2026."},{"key":"1999_CR56","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/MLR.0b013e31817d695c","volume":"46","author":"AG Hall","year":"2008","unstructured":"Hall AG, Harman JS, Zhang J. Lapses in Medicaid Coverage: Impact on Cost and Utilization Among Individuals With Diabetes Enrolled in Medicaid. Med Care. 2008;46:1219\u201325. https:\/\/doi.org\/10.1097\/MLR.0b013e31817d695c.","journal-title":"Med Care"},{"key":"1999_CR57","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/MLR.0000000000000751","volume":"55","author":"X Ji","year":"2017","unstructured":"Ji X, Wilk AS, Druss BG, Lally C, Cummings JR. Discontinuity of Medicaid Coverage: Impact on Cost and Utilization Among Adult Medicaid Beneficiaries With Major Depression. Med Care. 2017;55:735\u201343. https:\/\/doi.org\/10.1097\/MLR.0000000000000751.","journal-title":"Med Care"},{"key":"1999_CR58","doi-asserted-by":"publisher","unstructured":"Hacker K, Anies ME, Folb B, Zallman L. Barriers to health care for undocumented immigrants: a literature review. RMHP. 2015;175. https:\/\/doi.org\/10.2147\/RMHP.S70173.","DOI":"10.2147\/RMHP.S70173"},{"key":"1999_CR59","doi-asserted-by":"publisher","first-page":"e260034","DOI":"10.1001\/jamahealthforum.2026.0034","volume":"7","author":"N Huguet","year":"2026","unstructured":"Huguet N, Dinh D, Larson A, Suchocki A, Hwang J, DeVoe J, et al. Insurance Churn and Diabetes Outcomes Among Patients With Low Income. JAMA Health Forum. 2026;7:e260034. https:\/\/doi.org\/10.1001\/jamahealthforum.2026.0034.","journal-title":"JAMA Health Forum"},{"key":"1999_CR60","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2337\/dci25-0002","volume":"49","author":"MP Socal","year":"2026","unstructured":"Socal MP, Kandula NR, Bareamichael PI, Ballreich J, Odouard I, Kang S-Y, et al. Improving Affordability of Pharmaceutical Treatments for Diabetes: A Call for Action. Diabetes Care. 2026;49:30\u201343. https:\/\/doi.org\/10.2337\/dci25-0002.","journal-title":"Diabetes Care"},{"key":"1999_CR61","unstructured":"Williams E. May. Medicaid Coverage of and Spending on GLP-1s [Internet]. Kaiser Family Foundation. 2026 [cited 2026 May 11]. https:\/\/www.kff.org\/medicaid\/medicaid-coverage-of-and-spending-on-glp-1s\/?utm_source=chatgpt.com. Accessed 11 2026."},{"key":"1999_CR62","unstructured":"Centers for Medicare & Medicaid Services. The Inflation Reduction Act Lowers Health Care Costs for Millions of Americans [Internet]. Centers for Medicare & Medicaid Services. 2022 [cited 2026 Apr 28]. https:\/\/www.cms.gov\/newsroom\/fact-sheets\/inflation-reduction-act-lowers-health-care-costs-millions-americans. Accessed 28 Apr 2026."},{"key":"1999_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/01.mlr.0000108742.26446.17","volume":"42","author":"JD Piette","year":"2004","unstructured":"Piette JD, Wagner TH, Potter MB, Schillinger D. Health Insurance Status, Cost-Related Medication Underuse, and Outcomes Among Diabetes Patients in Three Systems of Care. Med Care. 2004;42:102\u20139. https:\/\/doi.org\/10.1097\/01.mlr.0000108742.26446.17.","journal-title":"Med Care"},{"key":"1999_CR64","unstructured":"Petek G. How Will the Changing Landscape Affect California\u2019s Health Care System? [Internet]. Legislative Analyst\u2019s Office; 2026 May. https:\/\/lao.ca.gov\/Publications\/Report\/5180. Accessed 28 Apr 2026."}],"container-title":["Journal of Immigrant and Minority Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-026-01999-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10903-026-01999-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-026-01999-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:32:10Z","timestamp":1789983130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10903-026-01999-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":64,"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1007\/s10903-026-01999-5","relation":{},"ISSN":["1557-1912","1557-1920"],"issn-type":[{"value":"1557-1912","type":"print"},{"value":"1557-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"30 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}